1. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009. 19:1167–1214.
2. Ashcraft MW, Van Herle AJ. Management of thyroid nodules. II: scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head Neck Surg. 1981. 3:297–322.
3. Uludag M, Yetkin G, Citgez B, Isgor A, Basak T. Autonomously functioning thyroid nodule treated with radioactive iodine and later diagnosed as papillary thyroid cancer. Hormones (Athens). 2008. 7:175–179.
4. Majima T, Doi K, Komatsu Y, Itoh H, Fukao A, Shigemoto M, Takagi C, Corners J, Mizuta N, Kato R, Nakao K. Papillary thyroid carcinoma without metastases manifesting as an autonomously functioning thyroid nodule. Endocr J. 2005. 52:309–316.
5. Mizukami Y, Michigishi T, Nonomura A, Yokoyama K, Noguchi M, Hashimoto T, Nakamura S, Ishizaki T. Autonomously functioning (hot) nodule of the thyroid gland. A clinical and histopathologic study of 17 cases. Am J Clin Pathol. 1994. 101:29–35.
6. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab. 1994. 79:1785–1789.
7. Boelaert K. The association between serum TSH concentration and thyroid cancer. Endocr Relat Cancer. 2009. 16:1065–1072.
8. Granter SR, Cibas ES. Cytologic findings in thyroid nodules after 131I treatment of hyperthyroidism. Am J Clin Pathol. 1997. 107:20–25.
9. Tezelman S, Grossman RF, Siperstein AE, Clark OH. Radioiodine-associated thyroid cancers. World J Surg. 1994. 18:522–528.